Leveraging technology to address unhealthy drug use in primary care settings

利用技术解决初级保健机构中不健康的药物使用问题

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The failure to identify and treat unhealthy drug use among patients seen in mainstream primary care settings represents a missed opportunity to improve population health. Screening, brief intervention, and referral to treatment (SBIRT) programs have been promoted to address this, but recent randomized clinical trials have demonstrated lack of efficacy. It is time to go 'back to the drawing board' to examine new models of care that could effectively address unhealthy drug use in primary care settings. SBIRT studies have only tested a 'specialist' model, which shifts the responsibility for screening and interventions onto a specialized health educator who is not part of the regular primary care team. An alternative model, which integrates screening and interventions into regular primary care, using the same approaches that are effective for other common chronic health conditions, may be more effective for reducing unhealthy drug use. Innovative application of health information technology can overcome barriers to implementing a primary care-integrated approach. The tablet computer-based Substance Use Screening and Intervention Tool (SUSIT) is designed to increase delivery of substance use brief interventions by primary care providers. The SUSIT is informed by the Technology Acceptance Model, and has three elements: 1) time and workflow constraints are addressed with patient self-administered screening completed before the clinical encounter, with results presented to the primary care provider at the point of care; 2) provider knowledge is enhanced with clinical decision support (CDS),which has proven effective at changing provider behavior to effectively address other health conditions; and 3) provider activation is improved with clinical reminders at every primary care visit. The screening component of the SUSIT has already been developed. The objective here is to build the clinical decision support, and then test the full SUSIT model with 10 primary care providers. A mixed methods approach will assess its acceptability and adoption among providers and patients, and gather preliminary data on its efficacy for reducing moderate-risk drug use (defined as unhealthy use that is below the threshold of a substance use disorder). A pre-post design will ascertain the dose of substance use intervention received and changes in drug use among patients enrolled in the screening only (SO) versus SUSIT intervention period (n=75 in each period). There are 3 specific aims: Aim 1 is to develop clinical decision support that assists primary care providers in carrying out a brief intervention. Aim 2 is to assess the impact of the SUSIT on dose of substance use brief intervention received by patients, and Aim 3 is to gather preliminary evidence on the efficacy of the SUSIT approach for reducing moderate-risk drug use. The innovation of the SUSIT approach is to leverage health information technology to support efficient and effective delivery of substance use screening and interventions. The significance of this research is that it develops and tests an alternative, practice-integrated model for addressing unhealthy drug use in primary care.
 描述(由适用提供):未能识别和治疗主流初级保健环境中的患者中使用不健康的药物使用,这代表了改善人口健康的错过的机会。已经促进了筛查,简短的干预和转诊对治疗计划(SBIRT)计划以解决这一问题,但最近的随机临床试验表明缺乏效率。现在是时候“回到绘图板”来检查新的护理模型,这些模型可以有效地解决初级保健环境中的不健康药物使用。 SBIRT研究仅测试了一个“专家”模型,该模型将筛查和干预的责任转移到不属于普通初级保健团队的专业健康教育者身上。一种将筛查和干预措施整合到常规初级保健中的替代模型,使用对其他常见慢性健康状况有效的方法,可能更有效地减少不健康的药物使用。健康信息技术的创新应用可以克服实施主要护理综合方法的障碍。基于平板电脑的药物使用筛查和干预工具(SUSIT)旨在增加初级保健提供者的简短干预措施的交付。 SUSIT由技术接受模型告知,并具有三个要素:1)时间和工作流程限制在临床相遇之前完成的患者自我管理筛查解决,并在护理点上呈现给初级保健提供者; 2)通过临床决策支持(CD)增强了提供者知识,该支持已被证明有效地改变了提供者行为以有效解决其他健康状况; 3)在每次初级保健访问时,通过临床提醒改善了提供者的激活。 SUSIT的筛选部分已经开发。这里的目的是建立临床决策支持,然后与10个初级保健提供者一起测试SUSIT模型。一种混合方法方法将评估其在提供者和患者中的可接受性和采用,并收集有关其减少现代风险药物使用有效性的初步数据(定义为不健康的使用,低于药物使用障碍的阈值)。验证前设计将确定接受药物使用干预措施的剂量以及仅参加筛查(SO)与SUSIT干预期的患者的药物使用变化(每个时期n = 75)。有3个具体目标:目标1是建立临床决策支持,以帮助初级保健提供者 进行简短的干预。目的2是评估SUSIT对患者接受的简短干预剂量的影响,而AIM 3是收集有关SUSIT方法减少现代风险药物使用的有效性的初步证据。 SUSIT方法的创新是利用健康信息技术来支持有效的物质使用筛查和干预措施。这项研究的意义在于,它开发并测试了一种替代性,实践综合的模型,用于解决初级保健中不健康的药物使用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer McNeely其他文献

Jennifer McNeely的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer McNeely', 18)}}的其他基金

NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
  • 批准号:
    10855627
  • 财政年份:
    2023
  • 资助金额:
    $ 25.43万
  • 项目类别:
NIDA Clinical Trials Network: New York Node - GY22 Integrating MOUD in Non-Medical Settings to Improve Treatment and Retention of Black/AA Persons
NIDA 临床试验网络:纽约节点 - GY22 在非医疗环境中整合 MOUD,以改善黑人/AA 人的治疗和保留
  • 批准号:
    10809985
  • 财政年份:
    2023
  • 资助金额:
    $ 25.43万
  • 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
  • 批准号:
    8667798
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
  • 批准号:
    8028169
  • 财政年份:
    2010
  • 资助金额:
    $ 25.43万
  • 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
  • 批准号:
    8323430
  • 财政年份:
    2010
  • 资助金额:
    $ 25.43万
  • 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
  • 批准号:
    8144836
  • 财政年份:
    2010
  • 资助金额:
    $ 25.43万
  • 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
  • 批准号:
    8521227
  • 财政年份:
    2010
  • 资助金额:
    $ 25.43万
  • 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
  • 批准号:
    8721383
  • 财政年份:
    2010
  • 资助金额:
    $ 25.43万
  • 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
  • 批准号:
    10580712
  • 财政年份:
    2001
  • 资助金额:
    $ 25.43万
  • 项目类别:

相似国自然基金

采用积分投影模型解析克隆生长对加拿大一枝黄花种群动态的影响
  • 批准号:
    32301322
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
山丘区农户生计分化对水保措施采用的影响及其调控对策
  • 批准号:
    42377321
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
跨期决策中偏好反转的影响因素及作用机制:采用体验式实验范式的综合研究
  • 批准号:
    72271190
  • 批准年份:
    2022
  • 资助金额:
    43 万元
  • 项目类别:
    面上项目
农民合作社视角下组织支持、个人规范对农户化肥农药减量增效技术采用行为的影响机制研究
  • 批准号:
    72103054
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
采用磁共振技术研究帕金森病蓝斑和黑质神经退变及其对大脑结构功能的影响
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
  • 批准号:
    10752930
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
Leveraging COVID-19 to modernize depression care for VA primary care populations
利用 COVID-19 实现 VA 初级保健人群的抑郁症护理现代化
  • 批准号:
    10636681
  • 财政年份:
    2023
  • 资助金额:
    $ 25.43万
  • 项目类别:
Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity
以运动为基础的戒烟治疗对高焦虑敏感性成人的疗效和实施
  • 批准号:
    10660767
  • 财政年份:
    2023
  • 资助金额:
    $ 25.43万
  • 项目类别:
Team Support to Improve Glycemic Control Using CGM in Diverse Populations (TEAM CGM)
团队支持在不同人群中使用 CGM 改善血糖控制 (TEAM CGM)
  • 批准号:
    10659721
  • 财政年份:
    2023
  • 资助金额:
    $ 25.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了